Rafarma Pharmaceuticals registered NOYA THERAPEUTICS LTD company in Israel
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) continues to develop business, expand, and strengthen its position in the Israeli market. The...
top of page
Поиск
Rafarma Pharmaceuticals plans to build a production unit of pharmacopeial substances in Yeruham
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) entered into negotiations with the Yeruham City Hall and the regulatory authorities of Israel...
Rafarma Pharmaceuticals has entered into negotiations with Israel Ariel University
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) has held a gathering with Ariel University. At the meeting, the parties discussed the...
Rafarma Pharmaceuticals appoints pharmaceutical industry leader Unt Raivo as new CEO
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is pleased to announce the appointment of Raivo Unt as company Chief Executive Officer. Mr. Unt...
Slavich Noya Technology announces H1 2022 results
Slavich Noya Technology, part of the Rafarma Pharmaceuticals (OTC: RAFA) group of companies, shared its achievements, sales and...
Rafarma Pharmaceuticals is continuing to develop smart packaging for a wide range of medicines
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) plans to announce the imminent launch of the most advanced pharmacovigilance and drug logistics...
Rafarma Pharmaceuticals has signed an agreement with Istem Medikal
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) has announced new international cooperation. Representatives of the company visited Turkey and,...
Rafarma Pharmaceuticals strengthens its position in Central Asia
Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development...
Rafarma Pharmaceuticals develops new liposome-based medicine for targeted therapy
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) has announced the development of a new drug for colon, pancreas and breast cancer treatment. An...
Rafarma Pharmaceuticals has developed a non-hardening gel for the radiopharmaceutical market
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) has created a promising for the pharmaceutical industry prototype gel base. A substance doesn't...
Rafarma Pharmaceuticals has entered into negotiations with the Institute of Isotopes Co. Ltd.
Rafarma Pharmaceuticals, Inc. (OTC: RAFA), BEBIG and the Institute of Isotopes Co. Ltd. have held a meeting in Budapest and discussed...
Rafarma Pharmaceuticals is working on a dietary supplement for the neurological deficits’ treatment
Rafarma Pharmaceuticals, Inc. (OTC: RAFA), where one of the priorities is the anti-aging therapy development, is starting a scientific...
Rafarma Pharmaceuticals’ project was included in the state program of Uzbekistan
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) presented a project for the immune cells oncological and sterile drugs production and...
bottom of page